Ischemic and Hemorrhagic Cerebrovascular Events after Left Ventricular Assist Devices (P2.281)

CONCLUSIONS: CVE remains a serious complication of LVAD and is associated with increased mortality and lower rates of OHT. Further investigations to identify risk factors for CVEs in LVAD patients and potential preventive measures including optimal ATRs are warranted. Disclosure: Dr. Tahsili-Fahadan has nothing to disclose. Dr. Curfman has nothing to disclose. Dr. Davis has nothing to disclose. Dr. Yahyavi-Firouz-Abadi has nothing to disclose. Dr. Nassif has nothing to disclose. Dr. LaRue has nothing to disclose. Dr. Ewald has received personal compensation for activities with Thoratec Corporation as a consultant and advisory board member. Dr. Zazulia has nothing to disclose.

Source: Neurology - April 8, 2015 Category: Neurology Authors: Tahsili-Fahadan, P., Curfman, D., Davis, A., Yahyavi-Firouz-Abadi, N., Nassif, M., LaRue, S., Ewald, G., Zazulia, A. Tags: Cerebrovascular Disease and Interventional Neurology: PFO and Other Cardiac Disease Source Type: research